A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
Acrivon Therapeutics
Acrivon Therapeutics
Artios Pharma Ltd
Eli Lilly and Company
Merck Sharp & Dohme LLC
Incyte Corporation
Yonsei University
Esperas Pharma Inc.
Incyte Corporation
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)